Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
NCT07598383Phase 2Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in atopic dermatitis (AD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Jun 2026; status: recruiting.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07598383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07598383.